Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
0.00%
N225
-0.46%
AXJO
-0.23%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

About

What does RGC do?
Regencell Bioscience Holdings focuses on developing traditional Chinese medicine and went public on July 16, 2021. It employs 12 staff and has launched three liquid standardized TCM formulae for ADHD and ASD.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Hong Kong
Website
https://www.regencellbioscience.com

Recently from Cashu

publisher logo
Cashu

Regencell Bioscience Holdings: Drawing Inspiration from Digital Gaming Evolution with Regal Riches

3 months ago
publisher logo
Cashu

Regencell Bioscience Holdings Explores Synergies in Health Tech and Digital Gaming with Regal Riches

3 months ago
publisher logo
Cashu

Regencell Bioscience Holdings: Barco Transforms Cinema with Advanced Laser Projection Systems

5 months ago

Key Stats

Market Cap
11.37B
Dividend Yield
0.00%
P/E Ratio
-599.42
EPS
-1.44
Revenue
-
Avg. Volume
206.58K
Stocks
Health Care
rgc
Regencell Bioscience Holdings
RGC
+12.63 (+121.91%)
22.99
USD
At close at Jul 04, 20:44 UTC
Summary
News
Signals
Benchmarks
Financials